StreetAlpha
13F holdings · Q3 2026

Finepoint Capital

Boston, MA · files as Finepoint Capital LP
Know the moment Finepoint Capital filesYou follow Finepoint Capital An email or push as soon as its next 13F reaches the SEC, with every stock it bought, sold and trimmed. Next 13F due by Feb 15, 2027
Holdings as of Sep 30, 2026Filed Nov 13, 2026Next filing due Feb 15, 2027CIK 1608126

Finepoint Capital reported 6 stocks worth $315M in its 13F filing for Q3 2026, filed Nov 13, 2026. Its largest holdings are QXO (86.7%), RXO (13.3%) and ANNAW (0.1%). Compared with Q2 2026, the fund opened new positions in CLDI, added to QXO and trimmed RXO.

Latest filing: what Finepoint Capital did in Q3 2026

vs Q2 2026
Filed 13F-HRView on SEC ↗
1 new1 added1 trimmed1 sold outBought about $61.3M · sold about $67.8M
New 1
Added 1
Trimmed 1
  • RXO−$67.8M−62%
Sold out 1
  • Calidi Biotherapeu$177

Dollar changes use the share change at the quarter end price. New and sold out show the whole position.

Reported value$315M−31.7% vs last quarter · $2.7B including options
Stocks held61 new · 1 sold out
Top 5 weight100.0%very concentrated
Turnover41%of the portfolio changed

Portfolio at a glance

share of reported value · Q3 2026
🔒 A free account shows every holding, what the fund sold and its options.Create free account

Holdings

#StockValueWeightSharesChangeShares, 8 qtrsHeld
1
QXO
Qxo Inc
$273M86.7%23.4M+5.2M (+29%)8 of 8
2
RXO
Rxo Inc
$41.8M13.3%2M−3.3M (−62%)5 of 8
3
ANNAW
Aleanna Inc
$154K0.1%490KNo change8 of 8
4
ANNA
Aleanna Inc
$73K0.0%28KNo change8 of 8
5
MNYWW
Moneyhero Limited
$23K0.0%895KNo change8 of 8
6
CLDI
Calidi Biotherapeutics Inc
$710.0%66New position1 of 8

Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.

Sold out

held in Q2 2026, gone in Q3 2026
StockValue last quarterShares sold
CALIDI BIOTHERAPEUTICS INC C
$1771,042

Options

valued at the underlying shares
StockTypeValueSharesChange
SPY
Spdr S&P 500 ETF TR
Put$984M1.3M−421,500
AMZN
Amazon Com Inc
Call$530M2.1M+2,128,300
QQQ
Invesco Qqq TR
Put$470M635K0
IWM
Ishares TR
Put$409M1.5M+1,472,000

Reported value

last 8 quarters
$867MQ4 '24
$593MQ1 '25
$504MQ2 '25
$543MQ3 '25
$533MQ4 '25
$417MQ1 '26
$461MQ2 '26
$315MQ3 '26

The value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.

Filings for Q3 2026

straight from the SEC
FiledFormQuarter
Nov 13, 202613F-HRQ3 2026SEC filing ↗

Other superinvestors

All hedge fund holdings →

Finepoint Capital 13F FAQ

What does Finepoint Capital own?

Finepoint Capital reported 6 stocks worth $315M in its 13F filing for Q3 2026, filed Nov 13, 2026. Its largest holdings are QXO (86.7%), RXO (13.3%) and ANNAW (0.1%). The table above lists every position in the filing (the top 10 without an account).

What did Finepoint Capital buy and sell in Q3 2026?

Compared with Q2 2026: 1 new positions, 1 added to, 1 trimmed and 1 sold out. New positions include CLDI.

When will Finepoint Capital file its next 13F?

Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.

How much is Finepoint Capital's portfolio worth?

The Q3 2026 filing reports $315M in US stocks ($2.7B including options). That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.